Citadel Advisors »

Ovid Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $43k 13k 3.22
2023-06-30 $133k 41k 3.28
2023-03-31 $178k 69k 2.58
2022-12-31 $88k 47k 1.86
2022-06-30 $52k 24k 2.17
2022-03-31 $217k 69k 3.14
2021-12-31 $412k 128k 3.21
2021-09-30 $542k 161k 3.36
2021-06-30 $602k 154k 3.91
2021-03-31 $1.1M 270k 4.03
2020-12-31 $517k 225k 2.30
2020-09-30 $1.1M 199k 5.74
2020-06-30 $464k 63k 7.38
2019-12-31 $158k 38k 4.15
2018-09-30 $82k 15k 5.64
2017-06-30 $204k 20k 10.47